12/20/2023 0 Comments Moneycontrol sun pharmaThe pharmaceutical company's overall net profit for the second quarter ended September 30, 2022, fell by 41% to Rs 409 crore.įor the quarter that ended September 30, 2022, the gold loan company recorded a 10.7% increase in consolidated net profit at Rs 409.48 crore. The television broadcaster's consolidated profit increased by 3% to Rs 407.4 crore on higher margin performance, although this was negatively impacted by the slow rise of its top line. The provider of logistics solutions claimed to have finished buying Rivigo Services and named Sreeram Venkateswaran as its CEO. ![]() The healthcare chain's consolidated earnings after tax for the second quarter ended in September 2022 was Rs 218.3 crore, up 67.1% from Rs130.6 crore in the same quarter the previous year. ![]() Sales rose 13.17 to Rs 31.54 crore in the quarter ended September 2022 as against Rs 27.87 crore during the previous quarter ended September 2021. The automotive batteries company reported a net profit of Rs246 crore for the second quarter that ended in September, an increase of 5% over the profit of Rs 234 crore for the same quarter the previous year.įor the quarter that concluded in September of FY23, the state-owned defence company recorded a staggering 75.3% year-over-year increase in earnings at Rs 75.8 crore.įor the September FY23 quarter, the media and entertainment company recorded a 58% fall in profit at Rs 112.8 crore. Net Loss of Sun Pharma Advanced Research Company reported to Rs 68.40 crore in the quarter ended September 2022 as against net loss of Rs 55.14 crore during the previous quarter ended September 2021. With an offer of Rs 377 crore, the real estate company claimed to be the top bidder for two neighbouring Noida property pieces. In the September quarter, the state-owned insurance recorded a multi-fold increase in net profit to Rs 15,952 crore, helped by gains from its investments. The following 10 stocks may show price movement in today's market. The Singapore Exchange's Nifty futures traded 38.5 points, or 0.21%, higher at 18,474.5, indicating that the stock markets may have a good start on Monday. Strengths: Leadership position in domestic formulations: Sun Pharma is the market leader in the domestic formulations segment, with a market share of 8.2 as on J(Source: All India Organisation of Chemists and Druggists AIOCD).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |